GLENMEDE TRUST CO NA - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 155 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$41,000
-22.6%
8,262
-5.0%
0.00%
Q2 2019$53,000
+32.5%
8,7000.0%0.00%
Q1 2019$40,000
+11.1%
8,7000.0%0.00%
Q4 2018$36,000
+1700.0%
8,700
+2330.2%
0.00%
Q1 2018$2,0000.0%3580.0%0.00%
Q4 2017$2,000
-99.4%
358
-98.9%
0.00%
-100.0%
Q2 2017$320,0000.0%33,9070.0%0.00%0.0%
Q1 2017$320,000
+9.6%
33,9070.0%0.00%0.0%
Q4 2016$292,000
-12.3%
33,907
-58.5%
0.00%
-33.3%
Q1 2014$333,000
+82.0%
81,662
+136.9%
0.00%
+50.0%
Q4 2013$183,000
+5.8%
34,4680.0%0.00%0.0%
Q3 2013$173,000
+13.1%
34,4680.0%0.00%0.0%
Q2 2013$153,000
+88.9%
34,468
+22.3%
0.00%
-77.8%
Q3 2012$81,000
-80.0%
28,179
-32.0%
0.01%
-59.1%
Q1 2012$406,000
+361.4%
41,439
+107.1%
0.02%
+29.4%
Q4 2009$88,000
-21.4%
20,008
-6.9%
0.02%
-26.1%
Q3 2009$112,000
+1.8%
21,4830.0%0.02%
-11.5%
Q2 2009$110,000
-22.0%
21,4830.0%0.03%
-35.0%
Q1 2009$141,000
-36.2%
21,4830.0%0.04%
-28.6%
Q4 2008$221,000
-22.5%
21,4830.0%0.06%
+1.8%
Q3 2008$285,000
-16.2%
21,4830.0%0.06%
-8.3%
Q2 2008$340,000
+217.8%
21,483
+30.7%
0.06%
+275.0%
Q1 2008$107,00016,4380.02%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
ARDSLEY ADVISORY PARTNERS LP 1,255,000$5,823,0001.12%
Phocas Financial Corp. 1,146,292$5,319,0000.54%
Worth Venture Partners, LLC 138,357$641,0000.36%
RICE HALL JAMES & ASSOCIATES, LLC 2,293,179$10,640,0000.34%
Monashee Investment Management LLC 240,000$1,114,0000.26%
BKS ADVISORS, LLC 118,587$550,0000.22%
PINNACLE ASSOCIATES LTD 1,418,391$6,581,0000.15%
FARALLON CAPITAL MANAGEMENT LLC 4,200,820$19,492,0000.15%
Fosun International Ltd 472,580$2,174,0000.14%
CARILLON TOWER ADVISERS, INC. 3,948,024$18,318,0000.13%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders